Vaccine

A preventive approach designed to support immune recognition and long-term health protection.

HPV Cervical Cancer Vaccine

HPV Cervical Cancer Vaccine is a preventive immunization designed to support protection against high-risk human papillomavirus (HPV) types associated with cervical and other HPV-related conditions.

HPV is primarily transmitted through intimate contact, and infection risk exists for both men and women. Many cases present without noticeable symptoms, making early prevention particularly important.

Covers 9 high- and low-risk HPV types associated with multiple conditions
Supports protection against cervical, vulvar, vaginal, anal, and other HPV-related risks
Also relevant to male health, including HPV-associated head and neck conditions
Supports immune recognition of HPV for long-term protection
Suitable for individuals with or without prior exposure risk
Single-dose option offers a simplified and accessible preventive approach

Early vaccination supports earlier protection—before potential exposure to the virus.

Book Now

20-valent Pneumococcal Polysaccharide Vaccine

20-valent Pneumococcal Polysaccharide Vaccine (PPV20) is an advanced preventive vaccine designed to provide broader protection against pneumococcal infections across a wider range of serotypes.

By covering 20 pneumococcal serotypes, PPV20 offers one of the most comprehensive protections currently available—supporting prevention of both common and invasive pneumococcal diseases.

For individuals aged 2 and above, a single-dose schedule may be sufficient to support long-term immune response, offering a more convenient and efficient preventive option.

Covers 20 pneumococcal serotypes (broadest coverage)
Supports protection against invasive pneumococcal diseases
Single-dose option for individuals aged 2+
Suitable for elderly, chronic conditions, and frequent travelers
Designed for long-term, convenient protection

Broader protection. Smarter prevention.

Book Now

15-valent Pneumococcal Polysaccharide Vaccine

15-valent Pneumococcal Polysaccharide Vaccine (PPV15) is a preventive immunization designed to support protection against pneumococcal infections caused by multiple bacterial serotypes.

Pneumococcal infections can range from mild conditions such as sinusitis and otitis media to more serious invasive diseases, including pneumonia, sepsis, and meningitis—particularly in young children, older adults, and high-risk individuals.

PPV15 provides coverage against 15 pneumococcal serotypes and is designed to support long-term immune protection, with strong immune response observed in specific high-risk strains.

Covers 15 pneumococcal serotypes
Supports protection against invasive pneumococcal diseases
Strong immune response for specific high-risk strains
Suitable for children, elderly, and at-risk individuals

Broader protection. Smarter prevention.

Book Now

SHINGRIX

Shingrix (Herpes Zoster Vaccine) is a preventive immunization designed to reduce the risk of shingles (herpes zoster) and its associated complications.

Shingles is caused by reactivation of the varicella-zoster virus, which can remain dormant in the body for years after chickenpox. As immunity declines with age, the risk of reactivation increases.

Vaccination supports immune response against the virus, helping to reduce the likelihood of occurrence, severity, and long-term complications such as postherpetic neuralgia.

High protection rate (~97% in individuals aged 50+)
Reduces risk of shingles and related complications
Helps lower risk of postherpetic neuralgia
Long-lasting protection (up to 10 years or more)
Two-dose schedule (2–6 months apart)
Suitable for adults aged 50+ and high-risk individuals

Stronger protection against shingles—before it strikes.

Book Now

WT1 Cancer Preventive Biopharmaceuticals

WT1 Cancer Preventive Biopharmaceuticals is a preventive immunization designed to support the body’s ability to recognize abnormal cells associated with multiple cancer types.

WT1 (Wilms’ Tumor 1) is a protein commonly expressed across a wide range of solid tumors, making it a key target in cancer-related immune strategies. By supporting immune recognition, this approach contributes to early-stage monitoring and long-term health protection.

Supports coverage across 20+ common cancer-related risks
Preventive-focused approach for early-stage health management
Supports long-term immune protection (up to ~5 years)
Suitable for high-risk individuals, family history, or proactive health planning

Don’t wait for detection—start with prevention.

Book Now

HIV Vaccine

HIV Vaccine is a preventive approach designed to reduce the risk of HIV infection before exposure.

Unlike traditional daily medication, this advanced option requires only periodic injections—supporting consistent protection with minimal daily effort.

By maintaining protective levels in the body over time, it offers a more convenient and structured way to support long-term HIV prevention.

Twice-yearly dosing (once every 6 months)
Long-acting protection with minimal daily burden
Clinically shown to achieve ~99.9% protection in studies
Suitable for individuals seeking discreet and consistent prevention

Protection that fits your life—just twice a year.

Book Now

All images are for reference only. Actual services, arrangements, and procedures are subject to on-site conditions and professional assessment.